
About Daaso Pharmaceuticals Private Limited
Data last updated:
Daaso Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U74999MH2018PTC305693. Its GSTIN is 27AAGCD5624C1ZX (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pallavi Amarjeet Wagh and Sushil Tarachand Bagde.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P. No.138 H. No. 180 Chandanshesh Nagar Anjani H. So. Hud Layout, Nagpur, Maharashtra, India – 440034.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.31 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net loss of ₹49.26 Lakh (net margin -37.6%) and EBITDA of -₹49.23 Lakh (EBITDA margin -37.5%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 20% over five years.
The company is associated with 1 brand: DAASO Pharma.
For more details, the company can be reached via its website daasopharma.com.
Company details
Contact details
Daaso Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its website is daasopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressP. No.138 H. No. 180 Chandanshesh Nagar Anjani H. So. Hud Layout, Nagpur, Maharashtra, India – 440034
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Daaso Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Daaso Pharmaceuticals operates one associated brand: DAASO Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, exporting, and supplying of medicines in India. | daasopharma.com |
Business activity
The main business activity of Daaso Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Daaso Pharmaceuticals Private Limited, buy the company report.
Financials of Daaso Pharmaceuticals Private Limited
FY 2025 filings availableDaaso Pharmaceuticals Private Limited reported revenue of ₹1.31 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 23% growth in the latest year. EBITDA fell 243% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹49.23 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹49.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -37.5% | ||||
| Net Profit Margin | -37.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Daaso Pharmaceuticals Private Limited, buy the company report.
Board of directors of Daaso Pharmaceuticals Private Limited
Daaso Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pallavi Amarjeet Wagh | Director | 23 Nov 2019 | 6 Years 11 Months | Current |
| Sushil Tarachand Bagde | Director | 27 Feb 2018 | 8 Years 8 Months | Current |
| Deepak Hiralal Gajghate | Director | 06 Jun 2022 | 4 Years 4 Months | Current |
Auditor
Daaso Pharmaceuticals Private Limited is audited by ASHISH KISHOR SHIVHARE & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHISH KISHOR SHIVHARE & CO | FY 2019 | 128341W |
Shareholding
The shareholding of Daaso Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Daaso Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Daaso Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Daaso Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Daaso Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCD5624C1ZX | Maharashtra | Active | 04 May 2018 |
To see the full GST registrations and return filing status of Daaso Pharmaceuticals Private Limited, buy the company report.
Recent activity
Daaso Pharmaceuticals Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Dhairyasheel Sharadrao Wagh ceased to be Director on 05 Mar 2024.
Frequently asked questions
Daaso Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 February 2018 (8+ years old) and is registered under CIN U74999MH2018PTC305693.
Daaso Pharmaceuticals has 3 current directors:
- Pallavi Amarjeet Wagh - Director
- Sushil Tarachand Bagde - Director
- Deepak Hiralal Gajghate - Director
The latest financial statements of Daaso Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Daaso Pharmaceuticals is 27AAGCD5624C1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Daaso Pharmaceuticals is U74999MH2018PTC305693. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Daaso Pharmaceuticals was incorporated on 27 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Nagpur.
Dhairyasheel Sharadrao Wagh ceased to be Director on 05 Mar 2024. Dipali Deepak Gajghate ceased to be Director on 08 Jun 2022. Deepak Hiralal Gajghate was appointed as Director on 06 Jun 2022. Daaso Pharmaceuticals has 5 board changes on record in total.
Daaso Pharmaceuticals can be reached through the website daasopharma.com. Its registered office is in Nagpur, Maharashtra, India.
The registered office of Daaso Pharmaceuticals is at P. No.138 H. No. 180 Chandanshesh Nagar Anjani H. So. Hud Layout, Nagpur, Maharashtra, India – 440034.
Daaso Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

